Zimmer Biomet Holdings

medical device company

ZBH NYSE · home listing ZBH SIX Swiss ISIN US98956P1021 SEC CIK 1136869 LEI 2P2YLDVPES3BXQ1FRB91
Follow Zimmer Biomet Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.1B +3.1% vs same quarter last year
Net income $191.6M −17% vs same quarter last year
EPS, diluted $1.00 −13.8% vs same quarter last year
Operating cash flow $560M +33.7% vs same quarter last year
Revenue by quarter
$2B
$1.9B
$2.1B
$2B
$2.2B
$2.1B
$2.2B
$2.1B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$2.5B$0$2.5B$5B$7.5B$10BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$8.2B$705.1M
FY24$7.7B$903.8M
FY23$7.4B$1B
FY22$6.9B$231.4M
FY21$6.8B$401.6M
FY20$6.1B−$138.9M
FY19$7B$1.1B
FY18$7.9B−$379.2M
FY17$7.8B$1.8B
FY16$7.7B$305.9M
FY15$6B$147M
FY14$4.7B$720.3M
FY13$4.6B$780.4M
FY12$4.5B$755M
FY11$4.5B$760.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%80%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2569.7%13.3%8.6%
FY2471.5%16.7%11.8%
FY2371.8%17.3%13.8%
FY2270.9%10%3.3%
FY2171.3%12.6%5.9%
FY2070.2%1.4%−2.3%
FY1972.1%16%16.3%
FY1871.4%0.4%−4.8%
FY1772.7%10.2%23.2%
FY1668.9%10.7%4%
FY1570%7.8%2.5%
FY1473.3%22.2%15.4%
FY1372.2%23.1%16.9%
FY1274.8%23.4%16.9%
FY1174.8%23%17.1%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.5B
FY24$1.3B
FY23$1.3B
FY22$1.2B
FY21$1.4B
FY20$1.1B
FY19$1.4B
FY18$1.6B
FY17$1.4B
FY16$1.4B
FY15$682.1M
FY14$915.6M
FY13$863.1M
FY12$1B
FY11$1.1B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$190.3M$487M
FY24$196M$868M
FY23$200.9M$692.2M
FY22$201.2M$126.4M
FY21$200.1M-
FY20$198.5M-
FY19$196.7M-
FY18$195.2M-
FY17$193.6M-
FY16$188.4M$415.5M
FY15$157.1M$150M
FY14$145.5M$400.9M
FY13$132.4M$720.8M
FY12$94.4M$485.6M
FY11-$1.1B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Zimmer Biomet
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearZimmer BiometHealthcare median
FY258.6%−30.6%
FY2411.8%−47%
FY2313.8%−58%
FY223.3%−80.4%
FY215.9%−71.9%
FY20−2.3%−62.2%
FY1916.3%−46.3%
FY18−4.8%−49.6%
FY1723.2%−45.9%
FY164%−36%
FY152.5%−38.4%
FY1415.4%−35.5%
FY1316.9%−37.1%
FY1216.9%−29.1%
FY1117.1%−27.9%